Table 3

Mean changes in lipid levels in psoriasis patients and non-psoriasis subjects from 5 years before to 5 years after psoriasis incidence/index date based on random effects models
Lipid measure Five-year change before the psoriasis incidence/index date Five-year change after the psoriasis incidence/index date
Psoriasis Non-psoriasis Psoriasis Non-psoriasis
Total Cholesterol (TC) −6.2 (−11.7, -0.7)* −15.3 (−20.7, -9.9) −15.9 (−20.3, -11.4) −13.6 (−17.8, -9.5)
Low-density Lipoprotein −8.3 (−13.0, -3.6) −14.2 (−19.2, -9.2) −13.2 (−17.1, -9.2) −13.2 (−16.8, -9.5)
High-density Lipoprotein (HDL) 2.1 (0.8, 3.4) 1.2 (−0.1, 2.6) 1.4 (0.2, 2.5) 1.7 (0.6, 2.9)
Triglycerides 1.6 (−13.5, 16.6) −7.0 (−18.0, 4.0) −20.2 (−31.3, -9.0) −15.8 (−24.5, -7.2)
TC: HDL ratio −0.3 (−0.4, -0.1) −0.4 (−0.6, -0.2) −0.5 (−0.7, -0.4) −0.5 (−0.6, -0.3)

* (p=0.024) indicates difference between the trends in lipid changes between psoriasis and non-psoriasis cohorts. Values in parentheses are 95% confidence intervals.

Akkara Veetil et al.

Akkara Veetil et al. BMC Dermatology 2012 12:20   doi:10.1186/1471-5945-12-20

Open Data